MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, VRNA made $103,138K in revenue. $11,921K in net income. Net profit margin of 11.56%.

Income Overview

Revenue
$103,138K
Net Income
$11,921K
Net Profit Margin
11.56%
EPS
$0.02
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • Product And Service Other

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-06-30
2024-12-31
2024-09-30
Total revenue, net
103,138 12,212 5,624
Research and development
12,950 11,144 10,552
Cost of sales
4,756 680 543
Selling, general and administrative
72,127 38,185 35,196
Total operating expenses
89,833 50,205 46,291
Operating income/(loss)
13,305 -37,987 -40,667
Foreign exchange gain(loss)
--1,475
Research and development tax credit
0 1,185 1,612
Interest expense
--9,882
Interest income
4,302 3,504 4,750
Interest expense
6,822 5,886 -
Loss on extinguishment of debt
0 -913 -
Foreign exchange gain/(loss)
1,097 -42 -
Total other (expense)/income, net
-1,423 -2,152 -2,045
Income/(loss) before income taxes
11,882 -40,139 -42,712
Income tax benefit/(expense)
-39 3,346 250
Net income/(loss)
11,921 -43,485 -42,962
Profit/(loss) per share, basic (in dollars per share)
0.02 -0.067 -0.07
Profit/(loss) per share, diluted (in dollars per share)
0.02 -0.067 -0.07
Weighted-average shares outstanding, basic (in shares)
685,155,000 122,194 651,944,000
Weighted-average shares outstanding, diluted (in shares)
727,223,000 122,194 651,944,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Product And ServiceOther$199K Product$102,939K Total revenue, net$103,138K Operating income/(loss)$13,305K Total operatingexpenses$89,833K Income taxbenefit/(expense)-$39K Income/(loss) before incometaxes$11,882K Total other(expense)/income, net-$1,423K Foreign exchangegain/(loss)$1,097K Interest income$4,302K Selling, general andadministrative$72,127K Cost of sales$4,756K Research and development$12,950K Net income/(loss)$11,921K Interest expense$6,822K

Verona Pharma plc (VRNA)

Verona Pharma plc (VRNA)